Literature DB >> 31119553

Correction to: Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia.

Andrea Yap1,2, Maria A Lopez-Olivo3, Julia Dubowitz4,5, Jonathan Hiller4,5,6, Bernhard Riedel4,5,6.   

Abstract

There was an isolated error relating to the Oh et al. study (1) within our recurrence-free survival analysis. When the reported estimates for Oh et al. are corrected, the pooled hazard ratio (HR) is now 0.87; 95% confidence interval (CI), 0.66 to 1.15; P=0.32.

Entities:  

Year:  2019        PMID： 31119553     DOI： 10.1007/s12630-019-01381-0

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN： 0832-610X            Impact factor:   5.063


  1 in total

1.  Long-Term Oncologic Outcomes for Patients Undergoing Volatile Versus Intravenous Anesthesia for Non-Small Cell Lung Cancer Surgery: A Retrospective Propensity Matching Analysis.

Authors:  Tak Kyu Oh; Kwhanmien Kim; Sanghoon Jheon; Jaebong Lee; Sang-Hwan Do; Jung-Won Hwang; In-Ae Song
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302
  1 in total
  2 in total

Review 1.  Guidelines for Perioperative Care in Elective Abdominal and Pelvic Surgery at Primary and Secondary Hospitals in Low-Middle-Income Countries (LMIC's): Enhanced Recovery After Surgery (ERAS) Society Recommendation.

Authors:  Ravi Oodit; Bruce M Biccard; Eugenio Panieri; Adrian O Alvarez; Marianna R S Sioson; Salome Maswime; Viju Thomas; Hyla-Louise Kluyts; Carol J Peden; Hans D de Boer; Mary Brindle; Nader K Francis; Gregg Nelson; Ulf O Gustafsson; Olle Ljungqvist
Journal:  World J Surg       Date:  2022-05-31       Impact factor: 3.282

2.  The Intersection of Regional Anesthesia and Cancer Progression: A Theoretical Framework.

Authors:  Aaron R Muncey; Sephalie Y Patel; Christopher J Whelan; Robert S Ackerman; Robert A Gatenby
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.